Opioid-use Disorder Clinical Trial
Official title:
Capturing Opioid Use Disorder Electronically & Patient Reported Outcomes
Verified date | February 2024 |
Source | Yale University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
The goal of the project is to build a clinical data research infrastructure that will begin to enhance capacity to use electronic health record (EHR) data and patient reported outcomes measures (PROs) to conduct opioid related research in emergency departments (EDs). 200 adult patients with a history of non-medical opioid use, opioid use disorder, or acute opioid overdose will be enrolled and will be asked to complete three PRO surveys (baseline, 3 days post ED discharge, and 30 days post discharge).
Status | Completed |
Enrollment | 101 |
Est. completion date | February 16, 2020 |
Est. primary completion date | February 16, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adult patient presenting to the Yale New Haven Hospital York Street Campus emergency department - History of opioid use disorder or non-medical use of opioids, as measured by screening assessment OR receiving treatment for opioid overdose - Willingness and ability to complete electronic surveys via a smartphone or computer Exclusion Criteria: - <18 years of age - Inability to communicate in English - Inability to provide consent (for example, due to psychosis, intoxication, severe mental illness or other reason) - Transfer from the ED for psychiatric evaluation |
Country | Name | City | State |
---|---|---|---|
United States | Yale New Haven Hospital - York Street Campus - Emergency Department | New Haven | Connecticut |
Lead Sponsor | Collaborator |
---|---|
Yale University | National Drug Abuse Treatment Clinical Trials Network, National Institute on Drug Abuse (NIDA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Willingness to share EHR data with researchers | The proportion of people who qualify for study criteria and enroll in the study | once: at screening and enrollment | |
Primary | Electronic survey response | Response rate to patient reported outcomes via electronic follow-up survey | once: 3 day follow-up survey | |
Secondary | Treatment Effectiveness Assessment | Treatment Effectiveness Assessment (TEA) elicits patient responses that help the patient and the clinician quickly gauge patient progress in treatment and in recovery, according to the patients' sense of what is important within four domains (substance use, health, lifestyle, and community) established by prior research | once: 3 day follow-up survey | |
Secondary | Treatment Effectiveness Assessment | Treatment Effectiveness Assessment (TEA) elicits patient responses that help the patient and the clinician quickly gauge patient progress in treatment and in recovery, according to the patients' sense of what is important within four domains (substance use, health, lifestyle, and community) established by prior research | once: 30 day follow-up survey | |
Secondary | ED patients prescribed opioid use disorder medication | The proportion of participants prescribed opioid use disorder medication as part of routine emergency medical care | once: 3 day follow-up survey | |
Secondary | ED patients prescribed opioid use disorder medication | The proportion of participants prescribed opioid use disorder medication as part of routine emergency medical care | once: 30 day follow-up survey | |
Secondary | ED patients referred to substance use disorder treatment | The proportion of participants referred for substance use disorder treatment as part of routine emergency medical care | once: 3 day follow-up survey | |
Secondary | Patients enrolling in substance use disorder treatment | The proportion of participants referred for substance use disorder treatment who enroll in substance use disorder treatment | once: 30 day follow-up survey | |
Secondary | Patients filling opioid use disorder prescriptions | The proportion of participants prescribed opioid use disorder medication who fill the opioid use disorder prescription | once: 3 day follow-up survey | |
Secondary | Patients filling opioid use disorder prescriptions | The proportion of participants prescribed opioid use disorder medication who fill the opioid use disorder prescription | once: 30 day follow-up survey | |
Secondary | Lost-to-follow-up | Lost-to-follow-up rates | Up to 5 months | |
Secondary | Electronic survey response | Response rate to patient reported outcomes via electronic follow-up survey | once: 30 day follow-up survey |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04157062 -
An Open-Label Trial of Repetitive Transcranial Magnetic Stimulation for Opioid Use Disorder
|
N/A | |
Enrolling by invitation |
NCT04527926 -
STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy
|
N/A | |
Completed |
NCT04505540 -
Start Treatment and Recovery for Opioid Use Disorder
|
N/A | |
Completed |
NCT03065049 -
Transforming Recovery Through Exercise and Community
|
N/A | |
Completed |
NCT04080037 -
Assessing Opioid Care Practices Using CPV Patient Simulation Modules
|
N/A | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Suspended |
NCT05001789 -
Cognitive Functioning in Opioid Use Disorder
|
N/A | |
Active, not recruiting |
NCT04650386 -
Examining an Adaptive Approach to Providing Psychosocial Support to Buprenorphine Patients
|
N/A | |
Completed |
NCT03715634 -
Study of a Novel Subcutaneous Depot Formulation of Buprenorphine
|
Phase 1 | |
Enrolling by invitation |
NCT04991974 -
Opioid Use Disorder Treatment Linkage at Sexual Health Clinics Using Buprenorphine
|
Phase 2/Phase 3 | |
Completed |
NCT04122755 -
Single Ascending Dose Study of ALA-1000
|
Phase 1 | |
Recruiting |
NCT05028998 -
COVID-19-Related Opioid Treatment Policy Evaluation
|
||
Recruiting |
NCT04927143 -
Encouraging Abstinence Behavior in a Drug Epidemic
|
Phase 2 | |
Recruiting |
NCT05049460 -
Adjunctive Transcranial Stimulation to Reduce Impulsivity in Opiate Use Disorder
|
N/A | |
Completed |
NCT05047627 -
Digital Intervention to Treat Anxiety and Depression Among Persons Receiving Treatment for Opioid Use Disorder
|
N/A | |
Active, not recruiting |
NCT04129580 -
reSET-O RCT (Randomized Controlled Trial)
|
N/A | |
Recruiting |
NCT03923374 -
Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
|
||
Completed |
NCT04464421 -
SMART Effectiveness Trial
|
N/A | |
Suspended |
NCT02687360 -
Imaging the Effects of rTMS on Chronic Pain
|
N/A | |
Completed |
NCT04056182 -
Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment
|
Phase 2 |